CAXTON CORP

Q1 2014 13F-HR Holdings

Location
Princeton, NJ
Holdings as of
3/31/2014
Date filed
5/15/2014
Form type
13F-HR
Num holdings
3
Total value ($000)
$131,016
Net value change ($000)
-26,461 (-16.8%)
New positions
1
Sold out positions
1
Turnover %
0.4%
Sector allocation + QoQ delta (equities-only)
Prev filing: 2/14/2014 Next filing: 8/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q4 2013
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
COVIDIEN PLC 459 NEW
Top Reduces (Value $000, Stocks/ETFs)
SYNTA PHARMACEUTICALS CORP -26,621 -17.7%
CELATOR PHARMACEUTICALS INC -180 -2.5%
HALL -119 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type